Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.14% |
| 2 | Financials | 4.52% |
| 3 | Industrials | 4.17% |
| 4 | Healthcare | 3.91% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5326
Hyster-Yale Materials Handling
HY
$614M
| $1.04M | ﹤0.01% |
17,703
-9,820
| -36% | -$546K |
|
5327
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.66B
| $1.04M | ﹤0.01% |
20,077
+10,640
| +113% | +$554K |
|
5328
PUT
Globus Medical
GMED
$11.5B
| $1.04M | ﹤0.01% |
17,700
-600
| -3% | -$32.6K |
|
5329
PUT
Enovis
ENOV
$1.42B
| $1.04M | ﹤0.01% |
16,617
-35,499
| -68% | -$2.01M |
|
5330
CALL
Wave Life Sciences
WVE
$1.02B
| $1.04M | ﹤0.01% |
+129,700
| New | +$3.18M |
|
5331
PUT
Lazard
LAZ
$4.24B
| $1.04M | ﹤0.01% |
26,000
-3,400
| -12% | -$128K |
|
5332
PUT
Pediatrix Medical
MD
$2.15B
| $1.04M | ﹤0.01% |
37,400
+28,100
| +302% | +$705K |
|
|
AVDL
5333
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.04M | ﹤0.01% |
137,358
+111,422
| +430% | +$589K |
|
5334
DXP Enterprises
DXPE
$3.04B
| $1.04M | ﹤0.01% |
26,036
+11,006
| +73% | +$410K |
|
5335
CALL
MACOM Technology Solutions
MTSI
$23.5B
| $1.04M | ﹤0.01% |
39,000
-22,000
| -36% | -$525K |
|
5336
LGI Homes
LGIH
$1.32B
| $1.04M | ﹤0.01% |
+14,668
| New | +$1.12M |
|
|
IPG
5337
PUT
DELISTED
Interpublic Group of Companies
IPG
| $1.03M | ﹤0.01% |
44,800
-8,500
| -16% | -$187K |
|
5338
CALL
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $1.03M | ﹤0.01% |
23,500
+9,300
| +65% | +$397K |
|
5339
PUT
Brown-Forman Class B
BF.B
$12.8B
| $1.03M | ﹤0.01% |
15,300
-33,400
| -69% | -$2.17M |
|
5340
PUT
NGL Energy Partners
NGL
$2.12B
| $1.03M | ﹤0.01% |
91,200
+42,800
| +88% | +$477K |
|
5341
CALL
Cemex
CX
$16.2B
| $1.03M | ﹤0.01% |
272,900
+78,800
| +41% | +$300K |
|
5342
CALL
HealthEquity
HQY
$8.83B
| $1.03M | ﹤0.01% |
13,900
-51,700
| -79% | -$3.23M |
|
5343
CALL
W.R. Berkley
WRB
$25.9B
| $1.03M | ﹤0.01% |
33,525
-5,625
| -14% | -$174K |
|
5344
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$771M
| $1.03M | ﹤0.01% |
22,800
-6,214
| -21% | -$271K |
|
|
TELL
5345
CALL
DELISTED
Tellurian Inc.
TELL
| $1.03M | ﹤0.01% |
141,300
-11,000
| -7% | -$83.7K |
|
5346
Ardelyx
ARDX
$1.01B
| $1.03M | ﹤0.01% |
137,057
+117,217
| +591% | +$712K |
|
5347
PUT
Evolus
EOLS
$536M
| $1.03M | ﹤0.01% |
84,500
+37,400
| +79% | +$527K |
|
5348
Harmonic Inc
HLIT
$1.42B
| $1.03M | ﹤0.01% |
+131,611
| New | +$983K |
|
5349
Cal-Maine
CALM
$3.86B
| $1.03M | ﹤0.01% |
24,010
+13,527
| +129% | +$564K |
|
|
UCB
5350
United Community Banks
UCB
$4.43B
| $1.03M | ﹤0.01% |
33,248
-4,618
| -12% | -$140K |
|
Similar funds
Citadel Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.
Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.
- Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
- Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
- Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.